Pan-cancer proteogenomics connects oncogenic drivers to functional states

Clinical Proteomic Tumor Analysis Consortium, Yize Li, Eduard Porta-Pardo, Collin Tokheim, Matthew H. Bailey, Tomer M. Yaron, Vasileios Stathias, Yifat Geffen, Kathleen J. Imbach, Song Cao, Shankara Anand, Yo Akiyama, Wenke Liu, Matthew A. Wyczalkowski, Yizhe Song, Erik P. Storrs, Michael C. Wendl, Wubing Zhang, Mustafa Sibai, Victoria Ruiz-SerraWen Wei Liang, Nadezhda V. Terekhanova, Fernanda Martins Rodrigues, Karl R. Clauser, David I. Heiman, Qing Zhang, Francois Aguet, Anna P. Calinawan, Saravana M. Dhanasekaran, Chet Birger, Shankha Satpathy, Daniel Cui Zhou, Liang Bo Wang, Jessika Baral, Jared L. Johnson, Emily M. Huntsman, Pietro Pugliese, Antonio Colaprico, Antonio Iavarone, Milan G. Chheda, Christopher J. Ricketts, David Fenyö, Samuel H. Payne, Henry Rodriguez, Ana I. Robles, Michael A. Gillette, Chandan Kumar-Sinha, Alexander J. Lazar, Lewis C. Cantley, Gad Getz, Li Ding, Eunkyung An, Meenakshi Anurag, Jasmin Bavarva, Michael J. Birrer, Anna Calinawan, Michele Ceccarelli, Daniel W. Chan, Arul M. Chinnaiyan, Hanbyul Cho, Shrabanti Chowdhury, Marcin P. Cieslik, Felipe da Veiga Leprevost, Corbin Day, Marcin J. Domagalski, Yongchao Dou, Brian J. Druker, Nathan Edwards, Matthew J. Ellis, Myvizhi Esai Selvan, Steven M. Foltz, Alicia Francis, Tania J. Gonzalez Robles, Sara J.C. Gosline, Zeynep H. Gümüş, Tara Hiltke, Runyu Hong, Galen Hostetter, Yingwei Hu, Chen Huang, Emily Huntsman, Eric J. Jaehnig, Scott D. Jewel, Jiayi Ji, Wen Jiang, Lizabeth Katsnelson, Karen A. Ketchum, Iga Kolodziejczak, Jonathan T. Lei, Yuxing Liao, Caleb M. Lindgren, Tao Liu, Weiping Ma, Wilson McKerrow, Alexey I. Nesvizhskii, Chelsea Newton, Robert Oldroyd, Gilbert S. Omenn, Amanda G. Paulovich, Francesca Petralia, Boris Reva, Karin D. Rodland, Kelly V. Ruggles, Dmitry Rykunov, Sara R. Savage, Eric E. Schadt, Michael Schnaubelt, Tobias Schraink, Zhiao Shi, Richard D. Smith, Xiaoyu Song, Jimin Tan, Ratna R. Thangudu, Nicole Tignor, Joshua M. Wang, Pei Wang, Ying (Cindy) Wang, Bo Wen, Maciej Wiznerowicz, Xinpei Yi, Bing Zhang, Hui Zhang, Xu Zhang, Zhen Zhang

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

Cancer driver events refer to key genetic aberrations that drive oncogenesis; however, their exact molecular mechanisms remain insufficiently understood. Here, our multi-omics pan-cancer analysis uncovers insights into the impacts of cancer drivers by identifying their significant cis-effects and distal trans-effects quantified at the RNA, protein, and phosphoprotein levels. Salient observations include the association of point mutations and copy-number alterations with the rewiring of protein interaction networks, and notably, most cancer genes converge toward similar molecular states denoted by sequence-based kinase activity profiles. A correlation between predicted neoantigen burden and measured T cell infiltration suggests potential vulnerabilities for immunotherapies. Patterns of cancer hallmarks vary by polygenic protein abundance ranging from uniform to heterogeneous. Overall, our work demonstrates the value of comprehensive proteogenomics in understanding the functional states of oncogenic drivers and their links to cancer development, surpassing the limitations of studying individual cancer types.

Original languageEnglish
Pages (from-to)3921-3944.e25
JournalCell
Volume186
Issue number18
DOIs
StatePublished - Aug 31 2023

Keywords

  • CPTAC
  • cancer hallmark
  • oncogenic driver
  • pan-cancer
  • phosphoproteomics
  • protein complex
  • proteogenomics
  • proteomics
  • therapeutic target

Fingerprint

Dive into the research topics of 'Pan-cancer proteogenomics connects oncogenic drivers to functional states'. Together they form a unique fingerprint.

Cite this